Sigma Of Australia To Report U.S.$254 Million Loss From Past Buys
This article was originally published in PharmAsia News
Executive Summary
Australia's Sigma Pharmaceuticals, reeling from acquisitions it made several years ago, is expected to report a loss for the past year of more than U.S.$254 million